The 2022 global Sexually Transmitted Disease Diagnostics Market reached USD 91.50 billion, with an anticipated revenue Compound Annual Growth Rate (CAGR) of 5.4% projected over the forecast period, as per the latest report from Reports and Data.
STDs, including gonorrhea, syphilis, chlamydia, genital herpes, and Human Papillomavirus (HPV), can be effectively managed when detected early and treated with antibiotics. Neglected, these conditions can lead to severe and prolonged health issues. Timely identification of STDs not only increases the chances of minimizing their impact but also ensures the proper functioning of the body’s systems. Additionally, modern STD diagnostic technologies aid in the early detection of infections. Traditionally, the cultivation of microorganisms isolated from sample fluids has been instrumental in STD detection and swift result analysis, thus contributing to expected market revenue growth.
STD diagnostics encompass a variety of tests conducted in both laboratory and Point Of Care (POC) settings. These tests encompass chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, Chancroid, and others. They play a crucial role in determining whether an individual has acquired a sexually transmitted infection.
Access Free sample PDF Copy of the Report @
https://www.reportsanddata.com/download-free-sample/6652
Government initiatives and the introduction of novel products and diagnostic technologies for these diseases serve as significant drivers for market revenue growth. Furthermore, advancements in technology, such as the utilization of multiplexed immunoassays in STD detection, are contributing factors to the market’s revenue expansion.
Key players in the Sexually Transmitted Disease Diagnostics Market:
- Danaher
- Thermo Fisher Scientific Inc.
- Cepheid
- Bio-Rad Laboratories, Inc.
- Abbott
- BIOMERIEUX
- Hoffmann- La Roche Ltd.
- DiaSorin
- OraSure Technologies
- Hologic, Inc.
Some Key Highlights in the Report:
- In 2022, the CT segment dominated the global STD diagnostics market in terms of revenue. This prominence can be attributed to the increasing efforts of governments worldwide in tackling this disease. As an example, on March 7, 2022, the UK government launched the National Chlamydia Screening Programme (NCSP) with the primary aim of mitigating the adverse consequences of untreated chlamydia infection. Given that chlamydia’s harmful effects primarily affect women and individuals with female reproductive organs, opportunistic screening, which involves offering chlamydia tests to young people without symptoms, is primarily targeted at women. This approach also places emphasis on reducing the time between testing and treatment, improving partner notification, and implementing re-testing after treatment. Additionally, technological advancements in the detection of this disease are another key driver behind the revenue growth in this market. These advancements contribute to enhanced diagnosis and management of chlamydia infection, ultimately fueling the expansion of the market.
- During the forecast period, the laboratory devices sector is expected to witness substantial revenue growth in the global STD diagnostic market, mainly propelled by ongoing technological advancements. The timely detection of STDs plays a critical role in preventing severe health complications, some of which can be life-threatening. Individuals who are affected by these infections typically visit clinics or healthcare providers to provide samples such as urine, blood, oral fluid, and various other samples for thorough examination. These samples are then analyzed in a laboratory setting to identify the presence of bacteria, viruses, or parasites responsible for causing STDs. If an at-home STD test yields positive results, it is imperative to seek further evaluation and consultation from a medical professional.
- In 2022, the North American market accounted for the largest share of revenue in the global STD diagnostic market. This dominance can be attributed to numerous partnerships formed among various companies and organizations aimed at promoting STD testing. A notable example of such collaboration occurred on March 15, 2021, when Building Healthy Online Communities, TakeMeHome, and NASTAD came together to launch a program that facilitates the delivery of free HIV and STD test kits to individuals’ homes. This program includes test kits for syphilis, gonorrhea, and chlamydia and has already distributed over 5,000 HIV test kits in eight states across the United States. Furthermore, the increasing number of government initiatives in the region also significantly contributes to the rising revenue growth in the market.
Get in detailed Research Study @ https://www.reportsanddata.com/report-detail/sexually-transmitted-disease-diagnostics-market
For the purpose of this report, Reports and Data has segmented the global Sexually Transmitted Disease (STD) diagnostics market on the basis of Disease Type Outlook, Type of testing Outlook, Device Type Outlook, Product Type Outlook, Usability Outlook, End-use Outlook, and Regional Outlook:
Disease Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Chlamydia Trachomatis (CT) / Neisseria Gonorrhea (NG)
- Gonorrhea
- Human Immunodeficiency Virus (HIV)/ Acquired Immunodeficiency Syndrome(AIDS)
- Genital Herpes (HSV-1, HSV-2)
- Hepatitis B
- Syphilis
- Mycoplasma Genitalium
- Genital Warts
- Candidal Vaginitis
- Trichomoniasis (Trichomonas Vaginitis)
- Bacterial Vaginosis
- Human Papillomavirus (HPV)
- Other STDs
Type of Testing Outlook (Revenue, USD Billion; 2022 – 2032)
- Culture/Isolation of Organisms
- Molecular Test
- Immunology Assay
- Other Types of Testing
Device Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Laboratory Devices
- Point of Care (PoC) Devices
Product Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Testing Kit
- Testing Device
- Testing Strip/Chip
Usability Outlook (Revenue, USD Billion; 2022 – 2032)
- Reusable
- Disposable
End-use Outlook (Revenue, USD Billion; 2022 – 2032)
- Hospitals
- Homecare
- Diagnostic Centers
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/6652
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @
https://www.reportsanddata.com/request-customization-form/6652
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Laboratory Freezers Market, By Product Type (Ultra-low Temperature Freezers, Low Temperature Freezers, and Explosion-proof Freezers), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Medical Laboratories, and Others), and By Region Forecast to 2032
ELISPOT and Fluorospot Assay Market, By Product Type (ELISpot Assay Kits and Fluorospot Assay Kits), By Application (Diagnosis, Drug Discovery and Development, and Research), By End-use [Biotechnology and Pharmaceutical Companies, Contract Research Organizations (CROs), Academic and Research Institutes], and By Region Forecast to 2032
Non-Invasive Fat Reduction Market, By Technology (Cryolipolysis, Ultrasound, Low-Level Laser Therapy, and Others), By End-Use (Hospitals, Clinics, and Spas & Wellness Centers), and By Region Forecast to 2032
Veterinary Electrosurgery Market, By Product Type (Electrosurgical Generators, Electrosurgical Instruments, and Accessories), By Animal Type (Small Animals and Large Animals), By Application (General Surgery, Gynecological & Urological Surgery, Orthopedic Surgery, Ophthalmic Surgery, and Others), and By Region Forecast to 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-sexually-transmitted-disease-diagnostics-market